D2R / TRP channels
Name: D(2) dopamine receptor
(D2R)
Official Symbol: DRD2
provided by HGNC
Function:
Dopamine receptor whose activity is mediated by G proteins which inhibit adenylyl cyclase (By similarity).
Source: Reorganizing the protein space at the Universal Protein Resource (UniProt)
Nucleic Acids Res. 40: D71-D75 (2012).
| Species |
External DB
|
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Entrez Gene | UniprotKB | DIP | IntAct | MINT | BioGRID | STRING | IUPHAR-DB | KEGG | OMIM | |
Human
|
1813 |
P14416 |
DIP-5977N |
P14416 |
MINT-201447 |
108147 |
P14416 |
hsa:1813 |
126450 |
|
Mouse
|
13489 |
P61168 |
MINT-5313868 |
199306 |
P61168 |
mmu:13489 |
||||
Rat
|
24318 |
P61169 |
DIP-30883N |
P61169 |
MINT-4792453 |
246498 |
P61169 |
rno:24318 |
||
Biological Process:
- GO:0032147
: activation of protein kinase activity - GO:0021984
: adenohypophysis development - GO:0007195
: adenylate cyclase-inhibiting dopamine receptor signaling pathway - GO:0007628
: adult walking behavior - GO:0050482
: arachidonic acid secretion - GO:0031223
: auditory behavior - GO:0007409
: axonogenesis - GO:0048148
: behavioral response to cocaine - GO:0048149
: behavioral response to ethanol - GO:0048755
: branching morphogenesis of a nerve - GO:0021853
: cerebral cortex GABAergic interneuron migration - GO:0032922
: circadian regulation of gene expression - GO:0042417
: dopamine metabolic process - GO:0051482
: elevation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway - GO:0007631
: feeding behavior - GO:0002031
: G-protein coupled receptor internalization - GO:0007625
: grooming behavior - GO:0007243
: intracellular protein kinase cascade - GO:0007616
: long-term memory - GO:0007194
: negative regulation of adenylate cyclase activity - GO:0045776
: negative regulation of blood pressure - GO:0030336
: negative regulation of cell migration - GO:0008285
: negative regulation of cell proliferation - GO:0042321
: negative regulation of circadian sleep/wake cycle, sleep - GO:0060160
: negative regulation of dopamine receptor signaling pathway - GO:0046676
: negative regulation of insulin secretion - GO:0051898
: negative regulation of protein kinase B signaling cascade - GO:0050709
: negative regulation of protein secretion - GO:0051967
: negative regulation of synaptic transmission, glutamatergic - GO:1901386
: negative regulation of voltage-gated calcium channel activity - GO:0001976
: neurological system process involved in regulation of systemic arterial blood pressure - GO:0007270
: neuron-neuron synaptic transmission - GO:0030432
: peristalsis - GO:0046488
: phosphatidylinositol metabolic process - GO:0060158
: phospholipase C-activating dopamine receptor signaling pathway - GO:0043473
: pigmentation - GO:0051586
: positive regulation of dopamine uptake involved in synaptic transmission - GO:0070374
: positive regulation of ERK1 and ERK2 cascade - GO:0045745
: positive regulation of G-protein coupled receptor protein signaling pathway - GO:0060124
: positive regulation of growth hormone secretion - GO:0040018
: positive regulation of multicellular organism growth - GO:0002052
: positive regulation of neuroblast proliferation - GO:0002092
: positive regulation of receptor internalization - GO:0035815
: positive regulation of renal sodium excretion - GO:0045944
: positive regulation of transcription from RNA polymerase II promoter - GO:0035810
: positive regulation of urine volume - GO:0060134
: prepulse inhibition - GO:0008104
: protein localization - GO:0051481
: reduction of cytosolic calcium ion concentration - GO:0030814
: regulation of cAMP metabolic process - GO:0014059
: regulation of dopamine secretion - GO:0002027
: regulation of heart rate - GO:0048169
: regulation of long-term neuronal synaptic plasticity - GO:0043666
: regulation of phosphoprotein phosphatase activity - GO:0043266
: regulation of potassium ion transport - GO:0002028
: regulation of sodium ion transport - GO:0032228
: regulation of synaptic transmission, GABAergic - GO:0051209
: release of sequestered calcium ion into cytosol - GO:0001975
: response to amphetamine - GO:0048678
: response to axon injury - GO:0042493
: response to drug - GO:0034776
: response to histamine - GO:0001666
: response to hypoxia - GO:0010039
: response to iron ion - GO:0043278
: response to morphine - GO:0035094
: response to nicotine - GO:0009636
: response to toxin - GO:0007608
: sensory perception of smell - GO:0007416
: synapse assembly - GO:0001963
: synaptic transmission, dopaminergic - GO:0001659
: temperature homeostasis - GO:0008542
: visual learning - GO:0016055
: Wnt receptor signaling pathway
Source: The Gene Ontology Consortium. Gene ontology: tool for the unification of biology. Nat. Genet.. May 2000;25(1):25-9.
World Wide Web URL: http://www.geneontology.org/
World Wide Web URL: http://www.geneontology.org/
Disease:
- OMIM:126450
:
Dystonia, myoclonic
(OMIM:159900
)
Source: Online Mendelian Inheritance in Man, OMIM®. McKusick-Nathans Institute of Genetic Medicine,
Johns Hopkins University (Baltimore, MD), May, 2012.
World Wide Web URL: http://omim.org/
World Wide Web URL: http://omim.org/
Screening
Validation: In vitro validation
Validation: In vivo validation
Characterization
Functional consequence
|
top
|
Screening
|
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Experimental screening | Non-experimental screening | Reference | ||||||||
| TRP channel construct | Interactor source | |||||||||
| TRP channel | Interactor | Method | Species | Region | Species | Organ/tissue | Sample type | |||
| TRPC1 |
|
D2R | Yeast two-hybrid | Not used as a bait | Human | Fetal brain | cDNA library | 18261457 | ||
| TRPC4 |
|
D2R | Inference | Prediction | 18261457 | |||||
| TRPC5 |
|
D2R | Inference | Prediction | 18261457 | |||||
(
:
click the arrow icon to show interactions only between the corresponding TRP channel and the interactor)
:
click the arrow icon to show interactions only between the corresponding TRP channel and the interactor)
Screening
Validation: In vitro validation
Validation: In vivo validation
Characterization
Functional consequence
|
top
|
Validation: In vitro validation
|
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Assay with recombinant proteins | Reference | |||||||||
| TRP channel construct | Interactor construct | |||||||||
| TRP channel | Interactor | Method | Species | Region | Expression system | Species | Region | Expression system | ||
| TRPC1 |
|
D2R | Fusion protein-pull down assay | Human | 638-759 | E. coli | Human | 131-151 | E. coli | 18261457 |
| TRPC4 |
|
D2R | Fusion protein-pull down assay | Human | 621-893 | E. coli | Human | 131-151 | E. coli | 18261457 |
| TRPC5 |
|
D2R | Fusion protein-pull down assay | Human | 619-973 | E. coli | Human | 131-151 | E. coli | 18261457 |
(
:
click the arrow icon to show interactions only between the corresponding TRP channel and the interactor)
:
click the arrow icon to show interactions only between the corresponding TRP channel and the interactor)
Screening
Validation: In vitro validation
Validation: In vivo validation
Characterization
Functional consequence
|
top
|
Validation: In vivo validation
|
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Assay with endogenous proteins | Assay with overexpressed proteins | Reference | ||||||||
| Cell or tissue | Cell or tissue | TRP channel construct | Interactor construct | |||||||
| TRP channel | Interactor | Method | Species | Region | Species | Region | ||||
| TRPC1 |
|
D2R | Co-immunofluorescence staining | Monkey prefrontal cortex | 18261457 | |||||
| TRPC1 |
|
D2R | Co-immunoprecipitation | Rat striatal tissue | 18261457 | |||||
| TRPC1 |
|
D2R | Co-immunoprecipitation | Rat cortex tissue | 18261457 | |||||
(
:
click the arrow icon to show interactions only between the corresponding TRP channel and the interactor)
:
click the arrow icon to show interactions only between the corresponding TRP channel and the interactor)
Screening
Validation: In vitro validation
Validation: In vivo validation
Characterization
Functional consequence
|
top
|
Characterization
|
||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Binding region mapping | Stoichiometry | Affinity (Kd) | Reference | |||||||
| TRP channel | Interactor | |||||||||
| TRP channel | Interactor | Method | Species | Region | Species | Region | ||||
| TRPC1 |
|
D2R | Yeast two-hybrid | Human | 726-745 | Human | 131-151 | 18261457 | ||
| TRPC4 |
|
D2R | Yeast two-hybrid | Human | 712-731 | Human | 131-151 | 18261457 | ||
| TRPC5 |
|
D2R | Yeast two-hybrid | Human | 719-738 | Human | 131-151 | 18261457 | ||
(
:
click the arrow icon to show interactions only between the corresponding TRP channel and the interactor)
:
click the arrow icon to show interactions only between the corresponding TRP channel and the interactor)
Screening
Validation: In vitro validation
Validation: In vivo validation
Characterization
Functional consequence
|
top
|
Functional consequence
|
||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TRP channel | Interactor | Method | Post-translational modification | Subcellular trafficking | Activity | Reference | ||||||
| TRPC1 |
|
D2R | Cell surface biotinylation | Increase in plasma membrane level | 18261457 | |||||||
(
:
click the arrow icon to show interactions only between the corresponding TRP channel and the interactor)
:
click the arrow icon to show interactions only between the corresponding TRP channel and the interactor)







Screening